Min Jun

Dr Sradha Kotwal of @UNSW and @georgeinstitute has developed the Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE), aiming to identify an effective drug to prevent CKD progression #KidneyHealthForAll #WorldKidneyDay

Come work with us! We have an exciting opening for a biostatistician to join the @georgeinstitute's Renal & Metabolic Division Great opportunity to work on large-scale cardiorenal randomised trials and routinely collected data applynow.net.au/jobs/GEORGE694 DM me for details

"I wanted to look into an area of research that had the biggest impact on society." Hear more from Nelson about his work on cardiovascular prevention and his long-term goals for his future work via @heartfoundation: buff.ly/3IaQNjK

Kidney Function, Albuminuria and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis buff.ly/3Q22tca @_jeffreyha @DearbhlaKelly4 @brendonneuen @VladoPerkovic @MinJun____ @badves @georgeinstitute @UNSWMedicine #VisualAbstract

The Prevalence of #ChronicKidneyDisease in Australian #PrimaryCare: Analysis of a National General Practice Dataset #VisualAbstract by @jmteakell kireports.org/article/S2468-… @MinJun____ @brendonneuen @SradhaKotwal @Badves @davidpeiris @jardine_meg @VladoPerkovic @georgeinstitute

Improved uptake of SGLT2i in people with CKD has the potential to substantially reduce the incidence of kidney failure in Australia Implementation now critical to realising these population level benefits Our new paper #openaccess in @LancetRH_WPac thelancet.com/journals/lanwp…

Latest granular data on CKD trends in Australia CKD is common & increasing year on year UACR testing remains abysmally low Major opportunities for early detection & treatment to prevent cardiovascular & kidney disease Led by @MinJun____ in @KIReports: kireports.org/article/S2468-…

@rohinajoshi @UNSWAGSM @UNSW Congratulations Rohina!

What started as few short courses @UNSWAGSM in 2021 ended with an MBA @UNSW today.

#ICYMI, check out this #ICESKDT study by @_jeffreyha and team that focused on determining the benefit–risk profile of rivaroxaban versus warfarin for atrial fibrillation in patients with #CKD. pubmed.ncbi.nlm.nih.gov/37492112/ @ICESOntario @MinJun____ 1/

Congratulations to @SradhaKotwal for securing @nhmrc funding to test new treatments in people with #ChronicKidneyDisease at trial centres in Australia & other countries. 🔗bit.ly/3KksTE9

The largest & most comprehensive analysis of the association between SGLT2i, blood pressure variability & cardiorenal outcomes While SGLT2i reduce BP, they have little to no effect on BP variability New #openaccess in @JAHA_AHA led by @Fletcher_RA ahajournals.org/doi/full/10.11…

Sharing this real-world study 🇦🇺🇨🇦showing favorable⚖️ safety🩸& effectiveness of Riva vs Warfarin across broad range of kidney fn with some imp safety data in those with greatly ⏬ kidney fn @MinJun____ @georgeinstitute @UNSWMedicine doi.org/10.1016/j.xkme…

Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia 🇦🇺 and Canada 🇨🇦. @KidneyMed ➡️ bit.ly/3MD9wYl

Congratulations to Drs Majed Al Jeraisy, Mohammed Tawhari and @Ahmed_Shaman from @kaimrc_ksa for enrolling their FIRST three patients in TRACK. We welcome Saudi Arabia 🇸🇦 to the TRACK trial.

Do multifaceted interventions or care bundles reduce #Dialysis catheter related bloodstream infections? Our researchers @SradhaKotwal and team have published ✍️imp new findings from their @reducction trial today in the @bmj_latest: ▶️bmj.com/content/377/bm…

@reducction @SradhaKotwal @dialysisbloke @sarah_scoggan @NephMcDonald @georgeinstitute Also provides impt insights into the scale of Hawthorne effect in such evidence implementation studies

Our studies found that as many as 434 million people across Asia could have chronic kidney disease and that it affects women and men differently. Urgent action in Asia is needed to prevent and manage CKD, including equitable policies that address the needs of both women and men

@alta_schutte Oh no, sorry to hear Alta - hope you feel better soon. Take care

Is it okay to feel utterly frustrated to get #COVID19 (triple vaxxed!) from your kids on the 1st day you are supposed to fly in 2+ years? Then having to work on your #investigatorgrant with a massive headache? So glad I still have #CatsOfTwitter to lift my spirits 😻

Fantastic opportunity to work on practice changing trials and big data with collaborative colleagues, and to make a global impact - join us!! @GLDiTanna @MinJun____ @ArnottClare @SradhaKotwal @Badves @alta_schutte

@georgeinstitute @Badves @LaurentJBillot @Dr_WuJ @UNSWMedicine @BruceNeal1 @RobynNorton8 @UNSW @GLDiTanna @vjha126 @kidneybloke @VladoPerkovic @SimonePettigrew @ACTA_org Congratulations all, fantastic news and very well deserved!

Meet our freshly minted professors! Congratulations Prof @Badves, Prof @LaurentJBillot and Prof @Dr_WuJ on the well-deserved promotions! @UNSWMedicine